In-vitro and in-vivo study of the interference between Rift Valley fever virus (clone 13) and Sheeppox/Lumpy Skin disease viruses

por Safini, N., Bamouh, Z., Hamdi, J., Jazouli, M., Tadlaoui, K. O., El Harrak, M.
Publicado 2021

Safety and immunogenecity of a live attenuated Rift Valley fever vaccine (CL13T) in camels

por Daouam, S., Ghzal, F., Naouli, Y., Tadlaoui, K. O., Ennaji, M. M., Oura, C., EL Harrak, M.
Publicado 2016

Safety and immunogenicity of the Rift Valley fever arMP-12 ΔNSm21/384 candidate vaccine in pregnant ewes

por Boumart, Z., Bamouh, Z., Hamdi, J., Safini, N., Tadlaoui, K.O., Bettinger, G., Watts, D.M., Elharrak, M.
Publicado 2020